Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anita F Das

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Obstetrics and Gynecology|August 10, 2020
Re-examining the Meis Trial for Evidence of False-Positive ResultsBaha Sibai, George R Saade, Anita F Das
Antimicrobial Agents and Chemotherapy|November 7, 2012
Prospective study of the Wilson severity-of-illness scoring system for complicated skin and skin structure infectionsGeorge H Talbot, Tanya O'Neal, Anita F Das, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|October 15, 2020
Safety review of hydroxyprogesterone caproate in women with a history of spontaneous preterm birthBaha Sibai, George R Saade, Anita F Das, et al.
Contemporary Clinical Trials|August 18, 2016
Clinician-reported lesion measurements in skin infection trials: Definitions, reliability, and association with patient-reported painJohn H Powers, Anita F Das, Carisa De Anda, et al.
Antimicrobial Agents and Chemotherapy|March 8, 2017
Clinical Response of Tedizolid versus Linezolid in Acute Bacterial Skin and Skin Structure Infections by Severity Measure Using a Pooled Analysis from Two Phase 3 Double-Blind TrialsTaylor Sandison, Carisa De Anda, Edward Fang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 23, 2016
Early Clinical Response as a Predictor of Late Treatment Success in Patients With Acute Bacterial Skin and Skin Structure Infections: Retrospective Analysis of 2 Randomized Controlled TrialsDilip Nathwani, Ralph Corey, Anita F Das, et al.
Infectious Diseases and Therapy|September 23, 2018
Efficacy and Safety of Tedizolid and Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Injection Drug Users: Analysis of Two Clinical TrialsGregory J Moran, Carisa De Anda, Anita F Das, et al.
NEJM Evidence|June 24, 2025
Sulopenem versus Amoxicillin/Clavulanate for the Treatment of Uncomplicated Urinary Tract InfectionSailaja Puttagunta, Steven I Aronin, Jayanti Gupta, et al.
The New England Journal of Medicine|June 5, 2014
Once-weekly dalbavancin versus daily conventional therapy for skin infectionHelen W Boucher, Mark Wilcox, George H Talbot, et al.
The Lancet. Infectious Diseases|June 10, 2014
Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trialGregory J Moran, Edward Fang, G Ralph Corey, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Obstetrics and Gynecology|August 10, 2020
Re-examining the Meis Trial for Evidence of False-Positive ResultsBaha Sibai, George R Saade, Anita F Das
Antimicrobial Agents and Chemotherapy|November 7, 2012
Prospective study of the Wilson severity-of-illness scoring system for complicated skin and skin structure infectionsGeorge H Talbot, Tanya O'Neal, Anita F Das, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|October 15, 2020
Safety review of hydroxyprogesterone caproate in women with a history of spontaneous preterm birthBaha Sibai, George R Saade, Anita F Das, et al.
Contemporary Clinical Trials|August 18, 2016
Clinician-reported lesion measurements in skin infection trials: Definitions, reliability, and association with patient-reported painJohn H Powers, Anita F Das, Carisa De Anda, et al.
Antimicrobial Agents and Chemotherapy|March 8, 2017
Clinical Response of Tedizolid versus Linezolid in Acute Bacterial Skin and Skin Structure Infections by Severity Measure Using a Pooled Analysis from Two Phase 3 Double-Blind TrialsTaylor Sandison, Carisa De Anda, Edward Fang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 23, 2016
Early Clinical Response as a Predictor of Late Treatment Success in Patients With Acute Bacterial Skin and Skin Structure Infections: Retrospective Analysis of 2 Randomized Controlled TrialsDilip Nathwani, Ralph Corey, Anita F Das, et al.
Infectious Diseases and Therapy|September 23, 2018
Efficacy and Safety of Tedizolid and Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Injection Drug Users: Analysis of Two Clinical TrialsGregory J Moran, Carisa De Anda, Anita F Das, et al.
NEJM Evidence|June 24, 2025
Sulopenem versus Amoxicillin/Clavulanate for the Treatment of Uncomplicated Urinary Tract InfectionSailaja Puttagunta, Steven I Aronin, Jayanti Gupta, et al.
The New England Journal of Medicine|June 5, 2014
Once-weekly dalbavancin versus daily conventional therapy for skin infectionHelen W Boucher, Mark Wilcox, George H Talbot, et al.
The Lancet. Infectious Diseases|June 10, 2014
Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trialGregory J Moran, Edward Fang, G Ralph Corey, et al.
Pageof 5